000 01101 a2200361 4500
005 20250512230803.0
264 0 _c19840629
008 198406s 0 0 eng d
022 _a0361-5960
040 _aNLM
_beng
_cNLM
100 1 _aSessa, C
245 0 0 _aTeniposide in refractory ovarian cancer: a phase II study.
_h[electronic resource]
260 _bCancer treatment reports
_cMay 1984
300 _a815-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfusions, Parenteral
650 0 4 _aLeukopenia
_xchemically induced
650 0 4 _aMiddle Aged
650 0 4 _aNausea
_xchemically induced
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPodophyllotoxin
_xanalogs & derivatives
650 0 4 _aTeniposide
_xtherapeutic use
700 1 _aD'Incalci, M
700 1 _aLandoni, F
700 1 _aColombo, N
700 1 _aMangioni, C
773 0 _tCancer treatment reports
_gvol. 68
_gno. 5
_gp. 815-6
999 _c6722624
_d6722624